New York City has become the monkeypox capital of the U.S., with nearly 20% of the nation’s reported cases.
What Happened: According to the New York Post , the city recorded 119 cases as of Wednesday. That's up 50% from last week.
Across the U.S., at least 605 cases have been confirmed; none of the cases have resulted in fatalities and the disease is easily treatable with vaccines. In the U.S., the antiviral drug Jynneos from the Danish biotech company Bavarian Nordic (OTC: BVNRY ) was approved in 2015 as a monkeypox treatment.
Monkeypox is related to smallpox, but ...
Full story available on Benzinga.com